NCT01411930 - Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

August 31, 2011

Conditions

Diabetes

Interventions

DRUG

Intramuscular olanzapine, aripiprazole

"1. 1st clamp: single intramuscular 10.0 mg dose of olanzapine~2. 2nd clamp: single intramuscular 9.75 mg dose of aripiprazole"

DRUG

Intramuscular aripiprazole, olanzapine

"1. 1st clamp: single intramuscular 9.75 mg dose of aripiprazole~2. 2nd clamp: single intramuscular 10.0 mg dose of olanzapine"

Trial Locations (1)

VA San Diego Healthcare System, San Diego